Baccine

A pre-clinical biotechnology company developing innovative proprietary bacteria-based cancer vaccines.

Health Tech & Life Sciences
Active
Seed Rehovot, Israel Founded 2022
Last updated 2026-07-20
Total raised
Last: Undisclosed Round 2025-10
Stage
Seed
Founded
2022
Headcount
9
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Baccine is a pre-clinical biotechnology company focused on developing innovative proprietary bacteria-based cancer vaccines to offer new hope for cancer patients. The company's multi-acting approach aims to provide efficient immunotherapy treatments with increased response rates and reduced side effects through localized action. Baccine was established in collaboration with the Weizmann Institute of Science, building on years of research into cancer resistance mechanisms, the tumor microenvironment, and the role of bacteria in tumors. The Baccine platform utilizes attenuated tumor-homing bacteria to induce a local immune response, express neoantigens to activate T-cells, and optimize the tumor microenvironment with an immunotherapeutic payload. This approach aims for broad-spectrum cancer indications, maximized effects with minimized toxicity, multiple layers of operation for a vast immune response, and immune memory to reduce cancer recurrence.

Funding history · 2 rounds · — total

2025-09
Seed Undisclosed
★ Terra Venture Partners
2024-02
Pre-Seed Undisclosed
★ Marius Nacht

Headcount over time

From 9 (2024-03) to 9 (2025-04) · +0 (+0%) · 5 points · source: Finder history + radar grounding
110 2024-03 2025-04

Q&A

What is Baccine's primary focus?
Baccine is a pre-clinical biotechnology company developing innovative proprietary bacteria-based cancer vaccines for immunotherapy treatments.
When was Baccine founded?
Baccine was founded in February 2022.
Which institute did Baccine establish its operations with?
Baccine was established in conjunction with the Weizmann Institute of Science.
Who is the Co-founder and CEO of Baccine?
Guy Neev is the Co-founder and CEO of Baccine.
What is Baccine's current product stage?
Baccine's product is currently in the R&D stage.
What was Baccine's most recent funding round?
In October 2025, Baccine received funding from Terra Venture Partners.
Which investor participated in Baccine's March 2024 funding round?
Marius Nacht participated in Baccine's funding round in March 2024.

Team · 1

Professor Ravid Straussman
Founder · Scientific Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology
Business model
B2C

Highlights

Verified

Tags

cancer-therapycancercancer-research
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitebaccine.tech
LinkedInlinkedin.com/company/82659953

Identifiers & details

Founded2022-2
Employees (exact)9

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainbaccine.tech

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516415379
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-06-16
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events5 — people (2), shares_capital (2), other (1)
Registered addressאופנהיימר 4 רחובות

Recent registry events

DateEvent
2025-11-13עדכון דירקטורים-הוספת דירקטור
2025-11-13עדכון דירקטורים-הסרת דירקטור
2025-11-10שינוי בהרכב הון - מניות-פיצול מניה
2025-11-10שינוי בתקנון
2026-05-05הקצאת מניות